Calidi Biotherapeutics Reports Shareholder Vote
Ticker: CLDWW · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-action
TL;DR
Calidi Biotherapeutics had a shareholder vote on July 9th, details to follow.
AI Summary
Calidi Biotherapeutics, Inc. filed an 8-K on July 11, 2025, reporting on a matter submitted to a vote of security holders on July 9, 2025. The filing does not specify the details of the vote or the outcome.
Why It Matters
This filing indicates a significant corporate action or decision was put to a shareholder vote, which could impact the company's future direction or financial structure.
Risk Assessment
Risk Level: medium — The filing indicates a shareholder vote, which could lead to significant corporate changes, but the lack of detail on the vote's subject and outcome introduces uncertainty.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- July 9, 2025 (date) — Date of earliest event reported
- July 11, 2025 (date) — Filing date
- First Light Acquisition Group, Inc. (company) — Former company name
FAQ
What specific matter was submitted to a vote of Calidi Biotherapeutics' security holders on July 9, 2025?
The filing does not specify the exact matter submitted for the vote.
What was the outcome of the shareholder vote on July 9, 2025?
The filing does not disclose the results or outcome of the shareholder vote.
When did Calidi Biotherapeutics, Inc. change its name from First Light Acquisition Group, Inc.?
The date of the name change was April 6, 2021.
What is the principal executive office address for Calidi Biotherapeutics, Inc.?
The address is 4475 Executive Drive, Suite 200, San Diego, CA 92121.
What is Calidi Biotherapeutics, Inc.'s telephone number?
The company's telephone number is (858) 794-9600.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding Calidi Biotherapeutics, Inc. (CLDWW).